Compare AdaptHealth Corp (AHCO) vs Remitly Global Inc (RELY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AdaptHealth Corp vs Remitly Global Inc — how do they compare? AdaptHealth Corp trades at $5.83 (market cap $753.09M), while Remitly Global Inc trades at $24.16 (market cap $4.97B). The key difference: Remitly Global Inc is far larger — about 6.6× AdaptHealth Corp's market cap, and Remitly Global Inc is trading nearer its 52-week high, AdaptHealth Corp nearer its low. Which is the better fit depends on your goals.
| AHCO | RELY | |
|---|---|---|
Market Cap | $753.09M | $4.97B |
Sector | Health | Technology |
52-Week High | $13.38 | $25.93 |
52-Week Low | $5.22 | $12.20 |
Enterprise Value | $2.77B | $4.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AdaptHealth Corp. (AHCO) trades at $5.74, up 9.96% in the last session, yet remains under pressure with a bearish technical signal and recent earnings misses. The company reported a Q2 2026 net loss of $228 million with a -6.82% margin, while selling its diabetes unit to focus on sleep and respiratory care. Valuation ratios show a low P/S of 0.23 and P/B of 0.55, but negative profitability metrics highlight operational challenges.
The outlook is mixed: analyst consensus is bullish with a $11 price target, but risks include ongoing losses, fraud investigations, and cost overruns in fixed-price contracts. Upside depends on successful business restructuring and margin improvement, while downside risks from legal and execution issues persist.
RELY trades at $23.87, up 3.15% today, with a bullish technical signal from moving averages. The company reported strong Q2 2026 results, beating EPS estimates with $0.93 actual versus $0.12 expected, and revenue growth of 20% year-over-year. Net income turned positive in 2025 at $67.93 million, reversing prior losses, with a robust ROE of 32.25%. Recent news highlights expansion into new financial services like the Global Card and a UAE license, driving investor optimism.
Outlook is positive with a consensus price target of $31.00, implying 30% upside, supported by 92% analyst buy ratings. Key opportunities include market share gains and new revenue streams, while risks involve execution of growth initiatives and competitive pressures in the remittance sector. The stock's valuation at a P/E of 16.99 appears reasonable given accelerating profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AdaptHealth Corp
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →About Remitly Global Inc
Remitly Global Inc provides integrated financial services to immigrants, including helping customers send money internationally in a quick, reliable, and more cost-effective manner by leveraging digital channels. It supports cross-border transmissions across the globe. Its revenue is generated on transaction fees charged to customers and foreign exchange spreads between the foreign exchange rate offered to customers and the foreign exchange rate on the company's currency purchases.
Read more on RELY →
